A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
2,5-Dimethoxyamphetamine
Ethyl loflazepate
The risk or severity of adverse effects can be increased when Ethyl loflazepate is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Flunitrazepam
The risk or severity of adverse effects can be increased when Flunitrazepam is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Chlorhexadol
The risk or severity of adverse effects can be increased when Chlorhexadol is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Desomorphine
The risk or severity of adverse effects can be increased when Desomorphine is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Delorazepam
The risk or severity of adverse effects can be increased when Delorazepam is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Difenoxin
The risk or severity of adverse effects can be increased when Difenoxin is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Dichloralphenazone
The risk or severity of adverse effects can be increased when Dichloralphenazone is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Camazepam
The risk or severity of adverse effects can be increased when Camazepam is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Barbital
The risk or severity of adverse effects can be increased when Barbital is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
4-Methoxyamphetamine
The risk or severity of adverse effects can be increased when 4-Methoxyamphetamine is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Seproxetine
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Seproxetine.
2,5-Dimethoxyamphetamine
Sodium oxybate
The risk or severity of adverse effects can be increased when Sodium oxybate is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Perampanel
The risk or severity of adverse effects can be increased when Perampanel is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Paraldehyde
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Paraldehyde.
2,5-Dimethoxyamphetamine
Lefamulin
Lasmiditan may decrease the excretion rate of Lefamulin which could result in a higher serum level.
2,5-Dimethoxyamphetamine
Acetyldigoxin
Lasmiditan may decrease the excretion rate of Acetyldigoxin which could result in a higher serum level.
2,5-Dimethoxyamphetamine
Metildigoxin
Lasmiditan may decrease the excretion rate of Metildigoxin which could result in a higher serum level.
2,5-Dimethoxyamphetamine
Erdafitinib
The serum concentration of Lasmiditan can be increased when it is combined with Erdafitinib.
2,5-Dimethoxyamphetamine
Esketamine
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Esketamine.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3